These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18816647)

  • 21. Treatment of pyoderma gangrenosum, erythema nodosum, and aphthous ulcerations.
    Winter HS
    Inflamm Bowel Dis; 1998 Feb; 4(1):71. PubMed ID: 9552232
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.
    Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K
    Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Setkowicz M; Szybiński P; Bogdaszewska-Czabanowska J
    Przegl Lek; 2001; 58(10):945-9. PubMed ID: 11957826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Manifestations of Crohn Disease.
    Hagen JW; Swoger JM; Grandinetti LM
    Dermatol Clin; 2015 Jul; 33(3):417-31. PubMed ID: 26143422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologics for extraintestinal manifestations of IBD.
    Vavricka SR; Scharl M; Gubler M; Rogler G
    Curr Drug Targets; 2014; 15(11):1064-73. PubMed ID: 25198785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of extraintestinal manifestations in inflammatory bowel disease.
    Lakatos PL; Lakatos L; Kiss LS; Peyrin-Biroulet L; Schoepfer A; Vavricka S
    Digestion; 2012; 86 Suppl 1():28-35. PubMed ID: 23051724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Various skin manifestations related to inflammatory bowel disease: A nationwide cross-sectional study on the Korean population.
    Jo UH; Lee JY; Lee H; Kim DY; Kang S; Koh SJ; Park H
    J Dermatol; 2021 Apr; 48(4):431-438. PubMed ID: 33608949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    Hedin CRH; Vavricka SR; Stagg AJ; Schoepfer A; Raine T; Puig L; Pleyer U; Navarini A; van der Meulen-de Jong AE; Maul J; Katsanos K; Kagramanova A; Greuter T; González-Lama Y; van Gaalen F; Ellul P; Burisch J; Bettenworth D; Becker MD; Bamias G; Rieder F
    J Crohns Colitis; 2019 Apr; 13(5):541-554. PubMed ID: 30445584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease.
    Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P
    J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extraintestinal manifestations of inflammatory bowel disease.
    Bernstein CN
    Curr Gastroenterol Rep; 2001 Dec; 3(6):477-83. PubMed ID: 11696285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.
    Ruhl AP; Ganz JE; Bickston SJ
    Dig Dis Sci; 2007 Jan; 52(1):18-24. PubMed ID: 17160479
    [No Abstract]   [Full Text] [Related]  

  • 35. Dermatological signs during inflammatory bowel diseases.
    Feliciani C; De Simone C; Amerio P
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dermatologic Manifestations in Inflammatory Bowel Disease].
    Suh HY; Lee WJ; Na SY
    Korean J Gastroenterol; 2019 May; 73(5):285-293. PubMed ID: 31132835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyoderma Gangrenosum among Patients with Inflammatory Bowel Disease: A Descriptive Cohort Study.
    Weizman AV; Huang B; Targan S; Dubinsky M; Fleshner P; Kaur M; Ippoliti A; Panikkath D; Vasiliauskas E; Shih D; McGovern DP; Melmed GY
    J Cutan Med Surg; 2015; 19(2):125-31. PubMed ID: 25775631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Vavricka SR; Schoepfer A; Scharl M; Lakatos PL; Navarini A; Rogler G
    Inflamm Bowel Dis; 2015 Aug; 21(8):1982-92. PubMed ID: 26154136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant cells in pyoderma gangrenosum.
    Sanders S; Tahan SR; Kwan T; Magro CM
    J Cutan Pathol; 2001 Feb; 28(2):97-100. PubMed ID: 11168758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.